Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Khiron Life Sciences Corp
V.KHRN.H
Alternate Symbol(s):
KHRNF
|
KHRWF
|
V.KHRN.WT.H
Healthcare
Drug Manufacturers - Major
Cannabis
Khiron Life Sciences Corp. is a Canada-based medical cannabis company. The Company has two business units: Khiron Health Services, and Khiron Med.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:KHRN.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
Kerschbaumer
X
Post by
Kerschbaumer
on Nov 22, 2023 11:31am
Are we done?
Got this dog in my tfsa so may as well sit and wait for a miracle. Thoughts?
(10)
•••
zzstocks70
X
Post by
zzstocks70
on May 08, 2023 9:46am
Where is Chris? He got me in this way back
Thanks for the tax loss you pos
(4)
•••
DukeofEarl
X
Post by
DukeofEarl
on Sep 19, 2022 1:25am
Will a raise be required?
Khiron is sailing towards profitability. Will they make it though? My fear is another raise if a sensible debt deal can't be made. Dilution at this stage would be brutal. Will the German market
...more
(4)
•••
GreenTeam25
X
Post by
GreenTeam25
on Aug 30, 2022 7:49am
An International Growth Story!
click to learn more -->
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 06, 2022 9:22am
New Press Release - Medical Cannabis Leader Khiron Continues Global Expansion into Spain
Khiron's Medical Clinics and Distribution Growth Throughout Europe Follows Success in Latin American MarketplaceSince establishing a Spanish subsidiary in 2019, Khiron's scientific and medical team is recognized as cannabinoid experts in SpainKhiron continues its long-standing relationship with...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 28, 2022 8:01am
New Press Release - Medical Cannabis Innovator Khiron Continues Global Expansion as Industry Leader Throughout Europe and Latin America
Khiron Serves Record Number of Patients With Khiron Products Globally in Its Medical Treatment ClinicsTORONTO, June 28, 2022 /PRNewswire/ - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) the global medical cannabis leader, continues expansion of the Khiron end-to-end...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 23, 2022 4:00pm
New Press Release - Khiron Announces Results of 2022 Annual General and Special Meeting
TORONTO, June 23, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Latin America and Europe, announces the results of its 2022 Annual General and Special Meeting of...
read article.
(64)
•••
TomConstantine
X
Comment by
TomConstantine
on Jun 22, 2022 10:01pm
RE:ATB: Speculative Buy rating and $0.60 target price for KHRN
Good idea to go all in?
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 10, 2022 12:48pm
New Press Release - KHIRON LIFE SCIENCES ANNOUNCES CLOSING OF $4.6 MILLION OVERNIGHT BROKERED OFFERING INCLUDING FULL EXERCISE OF OVER-ALLOTMENT OPTION
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE DISSEMINATION, DISTRIBUTION, RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES/TORONTO, June 10, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or, the "Company") (TSXV: KHRN), (OTCQB: KHRNF...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 02, 2022 3:17pm
New Press Release - IIROC Trading Resumption - KHRN
VANCOUVER, BC, June 2, 2022 /CNW/ - Trading resumes in:Company: Khiron Life Sciences Corp.TSX-Venture Symbol: KHRNAll Issues: YesResumption (ET): 3:15 PM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 02, 2022 2:38pm
New Press Release - KHIRON LIFE SCIENCES ANNOUNCES PRICING AND SIZE OF OVERNIGHT BROKERED OFFERING
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE DISSEMINATION, DISTRIBUTION, RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES./TORONTO, June 2, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) is...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 02, 2022 8:42am
New Press Release - IIROC Trading Halt - KHRN
VANCOUVER, BC, June 2, 2022 /CNW/ - The following issues have been halted by IIROC:Company: Khiron Life Sciences Corp.TSX-Venture Symbol: KHRNAll Issues: YesReason: At the Request of the Company Pending NewsHalt Time (ET): 8:35 AMIIROC can make a decision to impose a temporary suspension (halt...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 01, 2022 4:38pm
New Press Release - KHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT BROKERED OFFERING
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE DISSEMINATION, DISTRIBUTION, RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES/TORONTO, June 1, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) is...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on May 31, 2022 9:28am
New Press Release - Khiron to Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, Expanding its European Footprint
The acquisition will accelerate Khiron's growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmaciesThe acquisition will provide Khiron with an EU GMP-certified European manufacturing and distribution hub for various pharmaceutical...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on May 31, 2022 8:48am
New Press Release - PharmaDrug Announces Execution Of an Agreement to Sell Its German Cannabis Asset to Khiron
Toronto, Ontario--(Newsfile Corp. - May 31, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), is pleased to announce that it has entered into an agreement on May 31, 2022 with Khiron Life Sciences Corp. (TSXV: KHRN) ("Khiron") to sell all of the outstanding...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GBC AG Investment Research Analyst Report Indicates Strong Growth Forecast for DynaCert
Expanding opportunity: The re-refined Group III market represents less than 1% of the industry
The Value Play: Invest in One of the Largest Gaming Media Networks in North America
Critical Mineral Executive Order Issued by President Donald Trump
Crypto Insights at Your Fingertips – View Now!